06_ELI_LILLY_C - ELI LILLY & COMPANY (C)1 Thomas...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon
1  Thomas Stewart ( The Wealth of Knowledge ), while admitting that financial and physical assets have not disappeared, extols the importance of intellectual capital in the creation of wealth in the emerging “new economy.” Baruch Lev ( Intangibles: Management, Measurement, and Reporting ) states, “wealth and growth in today’s economy are driven primarily by intangible (intellectual) assets. Physical and financial assets are rapidly becoming commodities, yielding at best an average return on investment.” As an example, important intellectual assets for the pharmaceutical industry are commercially viable drugs and the patents that protect those drugs. Eli Lilly reports that 2009 and 2010 worldwide sales of its products, all of which have patents, were as follows: December 31, (Dollars in millions) 2010 2009 Zyprexa $5,026.40 $4,915.70 Cymbalta
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 2
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 2

06_ELI_LILLY_C - ELI LILLY & COMPANY (C)1 Thomas...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online